| 1 | diaphragm development (GO:0060539) | 9.83758804 |
| 2 | arginine catabolic process (GO:0006527) | 9.56323847 |
| 3 | skeletal muscle organ development (GO:0060538) | 8.75930283 |
| 4 | pyrimidine nucleoside salvage (GO:0043097) | 8.18562836 |
| 5 | pyrimidine-containing compound salvage (GO:0008655) | 8.18562836 |
| 6 | cellular protein complex localization (GO:0034629) | 8.10194694 |
| 7 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 7.98609807 |
| 8 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 7.98479925 |
| 9 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 7.81858801 |
| 10 | arginine metabolic process (GO:0006525) | 7.67421034 |
| 11 | negative regulation of neurotransmitter transport (GO:0051589) | 7.63967777 |
| 12 | exogenous drug catabolic process (GO:0042738) | 7.26430759 |
| 13 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 7.08440295 |
| 14 | UMP biosynthetic process (GO:0006222) | 7.08440295 |
| 15 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 7.08440295 |
| 16 | UMP metabolic process (GO:0046049) | 7.08440295 |
| 17 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 7.03365259 |
| 18 | negative regulation of vascular permeability (GO:0043116) | 6.97383001 |
| 19 | response to lipoprotein particle (GO:0055094) | 6.89066146 |
| 20 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 6.81233742 |
| 21 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.06150874 |
| 22 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 6.03695506 |
| 23 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 5.89825900 |
| 24 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 5.77251382 |
| 25 | nucleotide salvage (GO:0043173) | 5.69155206 |
| 26 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.66433523 |
| 27 | negative regulation of potassium ion transport (GO:0043267) | 5.63403460 |
| 28 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 5.57298077 |
| 29 | regulation of guanylate cyclase activity (GO:0031282) | 5.55386248 |
| 30 | drug catabolic process (GO:0042737) | 5.53788270 |
| 31 | nucleoside salvage (GO:0043174) | 5.46757061 |
| 32 | protein complex localization (GO:0031503) | 5.40655639 |
| 33 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 5.33992348 |
| 34 | positive regulation of receptor biosynthetic process (GO:0010870) | 5.18006735 |
| 35 | regulation of neurotransmitter uptake (GO:0051580) | 5.16194763 |
| 36 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.08863176 |
| 37 | protein heterotrimerization (GO:0070208) | 5.03278704 |
| 38 | adenine nucleotide transport (GO:0051503) | 5.03175131 |
| 39 | activation of MAPKKK activity (GO:0000185) | 5.01124901 |
| 40 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.99718408 |
| 41 | histone H3-K4 methylation (GO:0051568) | 4.80817341 |
| 42 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 4.75064358 |
| 43 | regulation of mitochondrial translation (GO:0070129) | 4.66414549 |
| 44 | regulation of stem cell maintenance (GO:2000036) | 4.65778776 |
| 45 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.48874103 |
| 46 | lateral sprouting from an epithelium (GO:0060601) | 4.48398454 |
| 47 | negative regulation of protein kinase B signaling (GO:0051898) | 4.46919829 |
| 48 | mRNA stabilization (GO:0048255) | 4.44887092 |
| 49 | RNA stabilization (GO:0043489) | 4.44887092 |
| 50 | negative regulation of macrophage differentiation (GO:0045650) | 4.44059920 |
| 51 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 4.43752749 |
| 52 | nitric oxide biosynthetic process (GO:0006809) | 4.42001191 |
| 53 | negative regulation of granulocyte differentiation (GO:0030853) | 4.37057044 |
| 54 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.36624969 |
| 55 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 4.30044023 |
| 56 | CTP biosynthetic process (GO:0006241) | 4.25772600 |
| 57 | CTP metabolic process (GO:0046036) | 4.25772600 |
| 58 | hypotonic response (GO:0006971) | 4.23609835 |
| 59 | regulation of mRNA catabolic process (GO:0061013) | 4.21775332 |
| 60 | chromatin silencing (GO:0006342) | 4.18675876 |
| 61 | ribosomal small subunit assembly (GO:0000028) | 4.17011328 |
| 62 | nerve growth factor signaling pathway (GO:0038180) | 4.13945198 |
| 63 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 4.07213477 |
| 64 | negative regulation of alcohol biosynthetic process (GO:1902931) | 4.04520364 |
| 65 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 4.02445975 |
| 66 | purine nucleotide transport (GO:0015865) | 4.01485750 |
| 67 | purine ribonucleotide transport (GO:0015868) | 3.97809786 |
| 68 | regulation of protein deacetylation (GO:0090311) | 3.96040098 |
| 69 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.92822851 |
| 70 | urea cycle (GO:0000050) | 3.89197226 |
| 71 | positive regulation of mRNA catabolic process (GO:0061014) | 3.83983208 |
| 72 | myoblast fusion (GO:0007520) | 3.83787495 |
| 73 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.82611428 |
| 74 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.79009109 |
| 75 | neurotransmitter biosynthetic process (GO:0042136) | 3.78706004 |
| 76 | positive regulation of catecholamine secretion (GO:0033605) | 3.77176690 |
| 77 | ncRNA 3-end processing (GO:0043628) | 3.75271608 |
| 78 | nitric oxide mediated signal transduction (GO:0007263) | 3.69626660 |
| 79 | regulation of cilium assembly (GO:1902017) | 3.69592644 |
| 80 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.69022966 |
| 81 | regulation of oxidative phosphorylation (GO:0002082) | 3.68273036 |
| 82 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.64437589 |
| 83 | urea metabolic process (GO:0019627) | 3.60936719 |
| 84 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.60073864 |
| 85 | inactivation of MAPK activity (GO:0000188) | 3.55293936 |
| 86 | positive regulation of histone acetylation (GO:0035066) | 3.54890386 |
| 87 | oogenesis (GO:0048477) | 3.53417884 |
| 88 | regulation of cell size (GO:0008361) | 3.49044725 |
| 89 | peptidyl-cysteine modification (GO:0018198) | 3.48064983 |
| 90 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.45473056 |
| 91 | regulation of cGMP biosynthetic process (GO:0030826) | 3.40963416 |
| 92 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.40223842 |
| 93 | Rap protein signal transduction (GO:0032486) | 3.32891619 |
| 94 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.29569203 |
| 95 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 3.26612427 |
| 96 | regulation of synaptic vesicle transport (GO:1902803) | 3.26171962 |
| 97 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.25407990 |
| 98 | response to nerve growth factor (GO:1990089) | 3.25407990 |
| 99 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.24362181 |
| 100 | positive regulation of cell size (GO:0045793) | 11.0189984 |
KRT18P34 
